Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rare diseases. Alexion scientists are among the first in the world to unlock the therapeutic potential of inhibiting terminal complement, a group of proteins that play an important role in the body's immune response and can destroy healthy tissue in certain patients.
Currently working as a Senior Tax Associate in both compliance and reporting for one of the many international subsidiaries of Alexion.
Able to work as a tax professional while still a student at WCSU. Worked at a publicly traded specialty manufacturing company in their tax department and learned on the job. Graduated in 2004 and then worked as a Tax Associate at KPMG LLP in Hartford before moving to Alexion Pharmaceuticals.
Knowledgeable about accounting, consulting and corporate finance.